Your browser doesn't support javascript.
Covid-19: Contributions from Psychopharmacology.
Bauer, Michael; Juckel, Georg.
  • Bauer M; Department of Psychiatry and Psychotherapy, Medical Faculty, Carl Gustav Carus University Hospital, Technische Universität Dresden, Dresden, Germany.
  • Juckel G; Department of Psychiatry, Psychotherapy and Preventive Medicine, LWL University Hospital, Ruhr-Universität Bochum, Bochum, Germany.
Pharmacopsychiatry ; 55(1): 5-6, 2022 Jan.
Article in English | MEDLINE | ID: covidwho-1655722
ABSTRACT
The COVID-19 pandemic is causing a major burden on personal health, healthcare systems and the global economy. For the last two years the COVID-19 pandemic has dramatically changed our lives in many personal and professional areas. For millions of us, due to infection rates, but also to protection measures such as lockdowns the corona pandemic has significantly changed the way we work, how we live, and how we interact with technology. In addition to the development of effective vaccines, anti-viral and anti-inflammation strategies are of eminent importance to treat people with acute infection or at least prevent serious negative outcomes. In contrast to the fast development of several effective vaccines that were remarkably available already after one year of the pandemic, novel effective anti-viral compounds are still in development. The only currently used effective medications against severe SARS-CoV-2 virus infection are corticosteroids 1.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Psychopharmacology / COVID-19 Topics: Vaccines Limits: Humans Language: English Journal: Pharmacopsychiatry Year: 2022 Document Type: Article Affiliation country: A-1720-8855

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Psychopharmacology / COVID-19 Topics: Vaccines Limits: Humans Language: English Journal: Pharmacopsychiatry Year: 2022 Document Type: Article Affiliation country: A-1720-8855